Back to Search
Start Over
pH-Responsive Cross-Linked Low Molecular Weight Polyethylenimine as an Efficient Gene Vector for Delivery of Plasmid DNA Encoding Anti-VEGF-shRNA for Tumor Treatment
- Source :
- Frontiers in Oncology, Vol 8 (2018), Frontiers in Oncology
- Publication Year :
- 2018
- Publisher :
- Frontiers Media SA, 2018.
-
Abstract
- RNA interference (RNAi) is a biological process through which gene expression can be inhibited by RNA molecules with high selectivity and specificity, providing a promising tool for tumor treatment. Two types of molecules are often applied to inactivate target gene expression: synthetic double stranded small interfering RNA (siRNA) and plasmid DNA encoding short hairpin RNA (shRNA). Vectors with high transfection efficiency and low toxicity are essential for the delivery of siRNA and shRNA. In this study, TDAPEI, the synthetic derivative of low-molecular-weight polyethylenimine (PEI), was cross-linked with imine bonds by the conjugation of branched PEI (1.8 kDa) and 2,5-thiophenedicarboxaldehyde (TDA). This biodegradable cationic polymer was utilized as the vector for the delivery of plasmid DNA expressing anti-VEGF-shRNA. Compared to PEI (25 kDa), TDAPEI had a better performance since experimental results suggest its higher transfection efficiency as well as lower toxicity both in cell and animal studies. TDAPEI did not stimulate innate immune response, which is a significant factor that should be considered in vector design for gene delivery. All the results suggested that TDAPEI delivering anti-VEGF-shRNA may provide a promising method for tumor treatment.
- Subjects :
- 0301 basic medicine
Small interfering RNA
Cancer Research
lcsh:RC254-282
Small hairpin RNA
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
RNA interference
Gene expression
gene vector
tumor treatment
Vector (molecular biology)
Original Research
Polyethylenimine
Chemistry
RNA
Transfection
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Cell biology
polyethylenimine
030104 developmental biology
Oncology
anti-VEGF
030220 oncology & carcinogenesis
nanoparticles
Subjects
Details
- Language :
- English
- ISSN :
- 2234943X
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Frontiers in Oncology
- Accession number :
- edsair.doi.dedup.....ce26afc5327ec0abae9884d0f7dec463
- Full Text :
- https://doi.org/10.3389/fonc.2018.00354